Insider filings

Summit Therapeutics Inc. (SMMT)

NASDAQ · Healthcare · 195 insider filings · last filed 3 months ago

15
Open-market insider filings shown
0d
Median delay on the insider filings
within the two business day rule
15/0
Purchases and sales in the filings shown

About Summit Therapeutics Inc.

from the company's filings and listing
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Chief executive
Robert W. Duggan
Employees
265
Listed since
Mar 5, 2015
Market value
$14.0B
Price to earnings
-
Earnings per share
-$1.10
Dividend yield
-

www.smmttx.com

Earnings

6 reported quarters · next on Oct 19, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 23, 2026-$0.28-$0.27n/a$114KEPS missRevenue n/a
Q1 FY2026reported Apr 30, 2026-$0.24-$0.33n/a$54KEPS beatRevenue n/a
Q4 FY2025reported Feb 23, 2026-$0.29-$0.10n/a$56.8MEPS missRevenue n/a
Oct 20, 2025-$0.31-$0.18n/a$76.5MEPS missRevenue n/a
Q3 FY2025reported Aug 11, 2025-$0.76-$0.09n/an/aEPS missRevenue n/a
Q1 FY2025reported May 1, 2025-$0.09-$0.09n/an/aEPS beatRevenue n/a

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Apr 17, 2026
ExecutiveSalaryStock awardsOtherTotal
Manmeet SoniChief Operating Officer, Chief Financial Officer and D$617K$0$248.5M$249.1M
Mahkam ZanganehCo-Chief Executive Officer, President and Director$617K$0$245.4M$246.0M
Robert W. DugganCo-Chief Executive Officer and Chairman$0$0$172K$172K

The summary compensation table from the 2025 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Baker Bros. Advisors LP$477.7M32,786,348-9.9%4.21%
FMR LLC$146.3M10,043,947-7.5%1.29%
State Street Corp$139.0M9,536,796+35.7%1.23%
Blackrock, Inc.$138.8M9,529,041-1.3%1.22%
Vanguard Capital Management LLC$83.6M5,734,484+0.4%0.74%
UBS Group AG$76.3M5,233,798+42.2%0.67%
Vanguard Portfolio Management LLC$73.5M5,042,190-3.7%0.65%
Goldman Sachs Group Inc$65.8M4,513,399+1352.5%0.58%
Price T Rowe Associates Inc$56.7M3,893,820-53.0%0.50%
Point72 Asset Management, L.P.$53.9M3,697,803+371.5%0.48%
Geode Capital Management, LLC$50.0M3,427,263+3.4%0.44%
Millennium Management LLC$34.2M2,349,081+1760.3%0.30%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next SMMT filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

15 filings of 195 on record
InsiderActionSharesPriceValueTrade dateDelay
Robert W. DugganCo-Chief Executive OfficerBought3,810,000$13.12$50.0MJun 12, 20260d
Mahkam ZanganehCo-Chief Executive OfficerBought3,810,000$13.12$50.0MJun 12, 20260d
Manmeet Singh SoniCOO and CFOBought25,000$14.43$361KJun 4, 20260d
Mahkam ZanganehCo-Chief Executive OfficerBought100,000$14.60$1.5MJun 4, 20260d
Robert W. DugganCo-Chief Executive OfficerBought100,000$14.60$1.5MJun 4, 20260d
Robert W. DugganCo-Chief Executive OfficerBought26,680$18.74$500KOct 21, 20252d
Yu XiaDirectorBought533,617$18.74$10.0MOct 21, 20252d
Mahkam ZanganehCo-Chief Executive OfficerBought26,680$18.74$500KOct 21, 20252d
Mahkam ZanganehCo-Chief Executive OfficerBought5,000$18.07$90KSep 11, 20250d
Robert W. DugganCo-Chief Executive OfficerBought333,394$17.68$5.9MSep 10, 20251d
Mahkam ZanganehCo-Chief Executive OfficerBought333,394$17.68$5.9MSep 10, 20251d
Robert W. DugganCo-Chief Executive OfficerBought5,000$18.07$90KSep 11, 20250d
Mahkam ZanganehChief Executive OfficerBought · 3 lines80,321$3.72$299KMar 27, 20240d
Ankur DhingraChief Financial OfficerBought100,000$3.75$375KMar 26, 20241d
Mahkam ZanganehChief Executive OfficerBought30,000$3.75$113KMar 26, 20241d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Awards, option exercises and gifts (20)
InsiderEventSharesDate
Bhaskar AnandChief Accounting OfficerStock award30,000Jan 8, 2026
Alessandra CesanoDirectorStock award38,219Jan 2, 2026
Mostafa RonaghiDirectorStock award35,000Jan 2, 2026
Kenneth A. ClarkDirectorStock award52,796Jan 2, 2026
Robert F. BoothDirectorStock award42,180Jan 2, 2026
Jeff HuberDirectorStock award44,885Jan 2, 2026
Robert W. DugganCo-Chief Executive OfficerStock award11,232Jan 2, 2026
Yu XiaDirectorStock award35,000Jan 2, 2026
Mahkam ZanganehCo-Chief Executive OfficerStock award11,232Jan 2, 2026
Robert W. DugganCo-Chief Executive OfficerStock award14,247,597Oct 21, 2025
Manmeet Singh SoniCOO and CFOStock award53,361Oct 21, 2025
Bhaskar AnandChief Accounting OfficerStock award26,680Oct 21, 2025
Mahkam ZanganehCo-Chief Executive OfficerStock award14,247,597Oct 21, 2025
Bhaskar AnandChief Accounting OfficerStock award50,000Sep 18, 2025
Mahkam ZanganehCo-Chief Executive OfficerOption exercise74,545May 30, 2025
Robert W. DugganCo-Chief Executive OfficerOption exercise74,545May 30, 2025
Mahkam ZanganehCo-Chief Executive OfficerStock award11,030,558Apr 29, 2025
Robert W. DugganCo-Chief Executive OfficerStock award11,030,558Apr 29, 2025
Bhaskar AnandChief Accounting OfficerStock award675,000Apr 29, 2025
Manmeet Singh SoniCOO and CFOStock award11,200,000Apr 29, 2025

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling SMMT?

Across the 15 most recent open-market filings shown here, 15 were purchases and 0 were sales.

How quickly are SMMT trades disclosed?

Insider filings on this page reached the public a median of 0 days after the transaction, against the two business days Form 4 allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

also in Healthcare

See every company we track